We investigated the prognostic impact of the WT1 SNPs, in our whole cohort of 182 ccRCC patients, with a median OS of 49.5 months (range 1–300 months) and a median DSS of 49 months (range 1–293 months). Here, WT1 is linked to nonpapillary renal cell carcinoma.